| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Bartonella bovis Bermond et al. 2002 |
DSM No.: | 21464, Type strain dsm-21464 dsm21464 dsm 21464 Bartonella bovis |
Strain designation: | 91-4 |
Other collection no. or WDCM no.: | CIP 106692,CCUG 43828 |
Isolated from: | blood of a domestic cow |
Country: | France Ile de France |
Date of sampling: | before 19.05.2008 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- CIP; strain 91-4 {2008} <- Y. Piemont, ULP, Strasbourg, France |
Genbank accession numbers: | 16S rRNA gene: AF293391 GltA (gltA) gene
gltA gene sequence: AF293394 |
Cultivation conditions: | Medium 693 , microaerophilic, high humidity; grows slowly, 37°C
Complete DSMZ Media List |
Summary and additional information: | <- CIP; strain 91-4 {2008} <- Y. Piemont, ULP, Strasbourg, France. Blood of a domestic cow; France, Ile de France. Type strain. Taxonomy/description (8351). Sequence accession number(s): AF293391, AF293394. (Medium 693, 37°C, micoraerophilic, high humidity; grows slowly) |
Literature: | 8351 |
Risk group: | 2 (t) (classification according to German TRBA) |
Restrictions: | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
|
Supplied as: | Delivery form | | Prices | | actively growing culture | | 160,- € | | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. Note: Freight charges for Risk Group 2 microorganisms will apply. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |